Human BCL2L11 CRISPR gRNA in Lenti Particles
gRNA
PExp, GEEN
Lentiviral Vector
pLenti-U6-sgRNA-PGK-Neo
Ampicillin
U6 Promoter
unconjugated
Stable
Catalog No. ABIN5127242
Quick Overview for Human BCL2L11 CRISPR gRNA in Lenti Particles (ABIN5127242)
Gene
BIM (BCL2L11)
(BCL2-Like 11 (Apoptosis Facilitator) (BCL2L11))
Application
Protein Expression (PExp), Genome Editing with Engineered Nucleases (GEEN)
Insert
gRNA
Vector
Lentiviral Vector
Vector Backbone
pLenti-U6-sgRNA-PGK-Neo
Promoter
U6 Promoter, PGK Promoter
Bacterial Resistance
Ampicillin
Expression Type
Stable, Transient
-
-
Species
- Human
-
Purpose
- Individual gRNA against BCL2L11 in Lentiviral Particles with a Titer of >1x10e7 IU/mL. (Cas9 required separately)
-
Sequence
- ""226 CAATCACGGA GGTGAAG""
-
Specificity
- GRNAs are designed for use with Cas9 Nuclease only.
-
Components
- Lentiviral particles with an individual gRNA (300 μL) for a specific sequence of BCL2L11
-
Selectable Marker
- Neomycin
-
-
-
-
Application Notes
- Recommended for quality control: Restriction Enzyme Digest and Sequencing
-
Restrictions
- For Research Use only
-
-
-
Format
- Viral Particles
-
Storage
- -80 °C
-
Expiry Date
- 12 months
-
-
- BIM (BCL2L11) (BCL2-Like 11 (Apoptosis Facilitator) (BCL2L11))
-
Alternative Name
- BCL2L11
-
NCBI Accession
- NM_138621
Target
-
You are here:
